Literature DB >> 9873869

Menorrhagia in von Willebrand disease successfully treated with single daily dose tranexamic acid.

Y L Ong1, D R Hull, E E Mayne.   

Abstract

Four cases of menorrhagia in von Willebrand disease were successfully treated with tranexamic acid given in a single daily dose of 4 g for the first 3-5 days of the menstrual cycle. The pathophysiology and pharmacokinetics are discussed. The apparent improved efficacy and acceptability of this new dosing regime have been highlighted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873869     DOI: 10.1046/j.1365-2516.1998.00147.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

1.  High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

Review 2.  Tranexamic acid: a review of its use in the management of menorrhagia.

Authors:  Keri Wellington; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.